One-year results of intravitreal bevacizumab as an adjunct to trabeculectomy for neovascular glaucoma in eyes with previous vitrectomy.
作者信息
Miki A, Oshima Y, Otori Y, Matsushita K, Nishida K
出版信息
Eye (Lond). 2011 May;25(5):658-9. doi: 10.1038/eye.2011.58. Epub 2011 Mar 18.
Abstract
摘要
相似文献
1
One-year results of intravitreal bevacizumab as an adjunct to trabeculectomy for neovascular glaucoma in eyes with previous vitrectomy.
Eye (Lond). 2011 May;25(5):658-9. doi: 10.1038/eye.2011.58. Epub 2011 Mar 18.
2
Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma.
Br J Ophthalmol. 2008 Oct;92(10):1431-3. doi: 10.1136/bjo.2007.129833.
3
Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
J Glaucoma. 2010 Dec;19(9):622-6. doi: 10.1097/IJG.0b013e3181ccb794.
4
Subconjunctival bevacizumab as an adjunct to trabeculectomy in eyes with refractory glaucoma: a case series.
Korean J Ophthalmol. 2010 Feb;24(1):47-52. doi: 10.3341/kjo.2010.24.1.47. Epub 2010 Feb 5.
5
Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab.
Clin Exp Ophthalmol. 2011 May-Jun;39(4):318-23. doi: 10.1111/j.1442-9071.2010.02449.x. Epub 2010 Dec 23.
6
Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
Am J Ophthalmol. 2010 Jun;149(6):964-972.e1. doi: 10.1016/j.ajo.2010.01.008. Epub 2010 Apr 9.
7
Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
J Glaucoma. 2010 Mar;19(3):212-8. doi: 10.1097/IJG.0b013e3181aae928.
8
Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens.
Graefes Arch Clin Exp Ophthalmol. 2011 Oct;249(10):1547-52. doi: 10.1007/s00417-011-1761-2. Epub 2011 Aug 13.
9
Intraocular pressure following combined routes of bevacizumab-augmented trabeculectomy for refractory neovascular glaucoma.
Semin Ophthalmol. 2013 Mar;28(2):72-4. doi: 10.3109/08820538.2012.760612.
10
Medical and surgical treatment of neovascular glaucoma.
Int Ophthalmol Clin. 2011 Summer;51(3):27-36. doi: 10.1097/IIO.0b013e31821e5960.
引用本文的文献
1
Surgical Outcomes of Mitomycin-C Augmented Trabeculectomy in Neovascular Glaucoma and Prognostic Factors for Surgical Failure in Thailand.
Clin Ophthalmol. 2024 Nov 1;18:3111-3123. doi: 10.2147/OPTH.S485331. eCollection 2024.
2
Anti-vascular endothelial growth factor for neovascular glaucoma.
Cochrane Database Syst Rev. 2020 Feb 6;2(2):CD007920. doi: 10.1002/14651858.CD007920.pub3.
3
Efficacy and safety of intravitreal ranibizumab with panretinal photocoagulation followed by trabeculectomy compared with Ahmed glaucoma valve implantation in neovascular glaucoma.
Int J Ophthalmol. 2017 Mar 18;10(3):400-405. doi: 10.18240/IJO.2017.03.12. eCollection 2017.
4
Long-Term Outcomes and Prognostic Factors of Trabeculectomy following Intraocular Bevacizumab Injection for Neovascular Glaucoma.
PLoS One. 2015 Aug 14;10(8):e0135766. doi: 10.1371/journal.pone.0135766. eCollection 2015.
5
25-gauge microincision vitrectomy to treat vitreoretinal disease in glaucomatous eyes after trabeculectomy.
J Ophthalmol. 2014;2014:306814. doi: 10.1155/2014/306814. Epub 2014 Apr 22.
6
Anti-vascular endothelial growth factor for neovascular glaucoma.
Cochrane Database Syst Rev. 2013 Oct 2;10(10):CD007920. doi: 10.1002/14651858.CD007920.pub2.
7
Anti-VEGF Agents and Glaucoma Filtering Surgery.
J Ophthalmic Vis Res. 2013 Apr;8(2):182-6.
8
Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.
J Ocul Pharmacol Ther. 2013 Sep;29(7):612-8. doi: 10.1089/jop.2013.0009. Epub 2013 Jun 4.
本文引用的文献
1
Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma.
Acta Ophthalmol. 2010 Feb;88(1):96-102. doi: 10.1111/j.1755-3768.2009.01648.x. Epub 2009 Sep 23.
2
Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure.
Am J Ophthalmol. 2009 May;147(5):912-8, 918.e1. doi: 10.1016/j.ajo.2008.11.015. Epub 2009 Feb 5.
3
Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma.
Br J Ophthalmol. 2008 Oct;92(10):1431-3. doi: 10.1136/bjo.2007.129833.
4
Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma.
Adv Ther. 2008 May;25(5):438-43. doi: 10.1007/s12325-008-0047-5.
5
Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients.
Ophthalmologica. 2006;220(6):383-8. doi: 10.1159/000095865.
Zotero 插件